This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring a benzhydryl group and an azetidine ring, makes it a valuable intermediate in the creation of molecules targeting central nervous system disorders. It is often explored for its potential in modulating receptors or enzymes associated with neurological conditions, such as anxiety, depression, or cognitive impairments. Additionally, its hydrochloride salt form enhances solubility, making it suitable for formulation studies and preclinical testing. Researchers also investigate its role in designing compounds with improved bioavailability and therapeutic efficacy.